What does science say about CBD (cannabidiol) and Schizophrenia?
- We don’t say yes or no. We show what has been studied.
- Working in a lab or in animals does not mean it works in people.
- Don’t stop or change your treatment without talking to your doctor.
What has been studied
- Lab studies (cells)Tests on cells in a dish.Source: PubMed · as of 6 Nov 2026 · Open the search at PubMed1study
- Animal studiesTests in mice, rats or other animals.Source: PubMed · as of 6 Nov 2026 · Open the search at PubMed50studies
- Studies in peoplePublished studies with human participants.Source: PubMed · as of 6 Nov 2026 · Open the search at PubMed38studies
- Registered trials in peopleTrials entered in a public registry, whatever their result.ClinicalTrials.gov: 6 · as of 6 Nov 2026 · Open the search at ClinicalTrials.govEU CTIS: 0 · as of 6 Nov 2026 · Open the search at EU CTISBy phase:Phase 3 (4)Phase 2 (2)By status:Not yet recruiting (2)Recruiting (2)Running, not recruiting (2)Countries (13):Germany (4)Switzerland (3)Spain (3)United Kingdom (3)Greece (3)Italy (3)Netherlands (3)Austria (2)Israel (2)Canada (1)Denmark (1)Finland (1)United States (1)With a linked publication (results): 2 of 6The registries do not tell us here whether results were posted; a linked publication is shown instead.6trials
- Approved treatmentApproved by a medicines regulator for this disease.No
Examples of what we found
The trials
Phase 3
Stratification and Treatment in Early Psychosis Study -ASSIST
Not yet recruiting · Switzerland, Germany, Spain, United Kingdom, Greece, Israel, Italy, Netherlands
ClinicalTrials.gov · NCT07326124Phase 3
Stratification and Treatment in Early Psychosis Study - PROMOTE
Not yet recruiting · Austria, Canada, Switzerland, Germany, Spain, Finland, United Kingdom, Greece, Italy, Netherlands
ClinicalTrials.gov · NCT07434973Phase 3
Stratification and Treatment in Early Psychosis Study - ENHANCE
Recruiting · Austria, Switzerland, Germany, Spain, United Kingdom, Greece, Israel, Italy, Netherlands
ClinicalTrials.gov · NCT06778564Phase 3
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Recruiting · United States
ClinicalTrials.gov · NCT04411225Phase 2
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
Running, not recruiting · Denmark
ClinicalTrials.gov · NCT04105231Phase 2
Enhancing Recovery in Early Schizophrenia
Running, not recruiting · Germany
ClinicalTrials.gov · NCT02926859
Thinking of paying for it? Read this first
- Ask for published results. Stories, thank-you letters and "patients report" are not results. Ask where the results were published.
- Know what you pay for. Ask in writing: what exactly is included, who gets the money, and what happens if you stop.
- Ask your own doctor first. Some products interfere with chemotherapy, radiation or other medicines. Your treating doctor can check this.
- Do not stop standard treatment for it. Do not stop or delay your treatment without talking to your care team.
Other treatments people ask about
- Cannabis and cannabinoids (CBD, THC)Step: Large trials
- Curcumin (turmeric)Step: Large trials
- Fasting and fasting-mimicking dietStep: Large trials
- High-dose vitamin CStep: Large trials
- Ketogenic dietStep: Large trials
- MelatoninStep: Large trials
- MetforminStep: Large trials
- StatinsStep: Large trials
- Vitamin DStep: Large trials
- HyperthermiaStep: Reports in people
- IvermectinStep: Reports in people
Not medical advice. Talk to the care team before changing treatment.